Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com
Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Puma Biotechnology in a report on Friday, February 28th. […]
More Stories
Original Games and Familiar Brands: Two Creative Routes in Online Casino Entertainment
A familiar film title can make a game recognisable before anyone opens it. An original character has a different task,...
Weather System Off North Carolina Could Become Nor’Easter or Tropical Storm: What to Know
By T.J. Muscaro The National Weather Service and its National Hurricane Center are tracking a storm system sitting off the...
Wall Street Review: Nasdaq Sinks 4.48 Percent as Inflation Fears Hit AI Stocks
By Panos Mourdoukoutas The Nasdaq Composite fell 4.48 percent for the week as hotter-than-expected inflation data sent Treasury yields higher...
Republican Attorney General Candidate New York, Saritha Komatireddy, Lays Out Her Vision
By Juliette Fairley Fresh off a fiery political debate last week, Republican challenger Saritha Komatireddy on Oct. 15 laid out...
Chaos and Violence Grip France as Far-Left Mobs Storm City Halls, Torch Streets
By Etienne Fauchaire PARIS—Stones and fireworks were already flying across Place de la République before Saturday’s demonstration against rising costs...
High Gas Prices Could Be the Key Issue That Swings the Senate
By Jeremy Lott Enough voters are fixated on the price of fuel that it could be the deciding issue in...